J Korean Child Neurol Soc.
2010 May;18(1):112-116.
A Case of Pediatric Nephrolithiasis Associated with Topiramate Treatment
- Affiliations
-
- 1Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea. neuroandy@korea.com
- 2Seoul National University College of Medicine, Seoul, Korea.
Abstract
- Topiramate is an antiepileptic drug widely used to treat various seizures, mood disorders and migraine based on its various pharmacological mechanisms. Even though nephrolithiasis is listed as one of its side effects, there have been no cases reporting nephrolithiasis caused by use of topiramate on Korean pediatric patients. Since the use of topiramate is increasing in many patients, the possibility of nephrolithiasis after the treatment needs to be considered. Here, we report our experience in correcting neprholithiasis by simply discontinuing topiramate without administering any additional treatments.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A case of toxic epidermal necrolysis due to topiramate
- The Study for Therapeutic Effects of Topiramate on Pediatric Patients with Migraine, Especially Accompanied by Aura
- A New Approach to the Prophylaxis of Cyclic Vomiting: Topiramate
- Two Cases of Successful Treatment With Topiramate in Patients With Meniere's Disease With Migraine
- Factors Associated with Favorable Outcome of Topiramate Migraine Prophylaxis in Pediatric Patients
